Literature DB >> 4195925

Cellular compartmentalization of herpesvirus antigens during viral replication.

B Roizman, S B Spring, P R Roane.   

Abstract

HEp-2 cells infected with herpes simplex virus develop five distinct immunofluorescent elements. Three (small nuclear granules, large nuclear granules, and an amorphous mass filling the nucleus) contain antigens which react with a rabbit serum prepared against boiled infected cell debris. A labeled pool of human antibody revealed antigens making up cytoplasmic granules and those responsible for a diffuse cytoplasmic fluorescence. All five immunofluorescent elements are demonstrable with a rabbit serum prepared against unheated infected cell debris. Viral antigens are segregated in the nucleus or in the cytoplasm; within the limits of detection, each antigen accumulates in one compartment only. The antigens responsible for the diffuse cytoplasmic fluorescence and for the amorphous nuclear mass are synthesized early in infection; they are formed in arginine-deprived cells and exist in a form which does not sediment on centrifugation at 79,000 x g for 2 hr. The antigens comprising the nuclear and cytoplasmic granules arise relatively late in infection; they are not formed in arginine-deprived cells, and they are readily sedimented on centrifugation at 79,000 x g for 2 hr. Heating (60 C for 2 hr) confers on one or more cytoplasmic viral antigens a new specificity; the altered antigens are demonstrable with labeled rabbit anti-boiled infected cell serum which normally does not combine with cytoplasmic antigens.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4195925      PMCID: PMC375518     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  THE MULTIPLICATION OF HERPES SIMPLEX VIRUS. I. THE PROGRAMMING OF VIRAL DNA DUPLICATION IN HEP-2 CELLS.

Authors:  B ROIZMAN; L AURELIAN; P R ROANE
Journal:  Virology       Date:  1963-11       Impact factor: 3.616

3.  Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technic with a modification of its application.

Authors:  J D MARSHALL; W C EVELAND; C W SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

4.  A physical difference between two strains of herpes simplex virus apparent on sedimentation in cesium chloride.

Authors:  B ROIZMAN; P R ROANE
Journal:  Virology       Date:  1961-09       Impact factor: 3.616

5.  Immunochemical studies of poliovirus. IV. Alteration of the immunologic specificity of purified poliomyelitis virus by heat and ultraviolet light.

Authors:  B ROIZMAN; M M MAYER; P R ROANE
Journal:  J Immunol       Date:  1959-01       Impact factor: 5.422

6.  Cellular localization of Herpes simplex virus by means of fluorescent antibody.

Authors:  J LEBRUN
Journal:  Virology       Date:  1956-08       Impact factor: 3.616

7.  Polysomes and protein synthesis in cells infected with a DNA virus.

Authors:  R J Sydiskis; B Roizman
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

8.  Differentiation of nuclear and cytoplasmic herpesvirus antigens in infected cells.

Authors:  P R Roane; B Roizman
Journal:  Virology       Date:  1966-08       Impact factor: 3.616

9.  Electron microscopic observations on the development of herpes simplex virus.

Authors:  C MORGAN; H M ROSE; M HOLDEN; E P JONES
Journal:  J Exp Med       Date:  1959-10-01       Impact factor: 14.307

10.  Structure and development of viruses as observed in the electron microscope. I. Herpes simplex virus.

Authors:  C MORGAN; S A ELLISON; H M ROSE; D H MOORE
Journal:  J Exp Med       Date:  1954-08-01       Impact factor: 14.307

View more
  10 in total

1.  The effect of arginine deprivation on the cytopathogenic effect and replication of human cytomegalovirus.

Authors:  H M Garnett
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Herpes simplex virus products in productive and abortive infection. II. Electron microscopic and immunological evidence for failure of virus envelopment as a cause of abortive infection.

Authors:  S B Spring; B Roizman; J Schwartz
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

3.  Electron microscopy of herpes simplex virus. IV. Studies with ferritin-conjugated antibodies.

Authors:  S Nii; C Morgan; H M Rose; K C Hsu
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

4.  Combined fluorescent-antibody and electron microscopy study of Marek's disease virus-infected cell culture.

Authors:  K Nazerian; H G Purchase
Journal:  J Virol       Date:  1970-01       Impact factor: 5.103

5.  Precursor Products Found in Formaldehyde-fixed Lysates of BHK-21 Cells Infected with Pseudorabies Virus.

Authors:  R J Sydiskis
Journal:  J Virol       Date:  1969-09       Impact factor: 5.103

6.  Argininosuccinate synthetase 1 depletion produces a metabolic state conducive to herpes simplex virus 1 infection.

Authors:  Sarah L Grady; John G Purdy; Joshua D Rabinowitz; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

7.  Immunofluorescence in the study of Marek's disease. I. Detection of antigen in cell culture and an antigenic comparison of eight isolates.

Authors:  H G Purchase
Journal:  J Virol       Date:  1969-06       Impact factor: 5.103

8.  Feline herpesvirus infection in fused cultures of naturally resistant human cells.

Authors:  P Tegtmeyer; J F Enders
Journal:  J Virol       Date:  1969-05       Impact factor: 5.103

9.  Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma.

Authors:  I Royston; L Aurelian
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

10.  Virus-specific, labile, nonvirion antigen in herpesvirus-infected cells.

Authors:  G Tarro; A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.